The Endocrine Society today issued a Clinical Practice Guideline (CPG) advising against using testosterone treatment in healthy girls. Although the FDA approved testosterone therapy for the treatment of ailments affecting the testes, pituitary and hypothalamus, it hasn't been approved for treating age-related decrease in testosterone levels. The U.S. National Institute
on Aging is also expected to release the results of research on the safety of testosterone. The study included roughly 800 elderly men with low testosterone and symptoms related to this ailment, like http://tinyurl.com/jkhvqy9
sexual and physical dysfunction. The research is anticipated to shed more light on the security of testosterone treatment since the heart health of the men was carefully monitored.
The recent contradictory findings on testosterone treatment prompted Patel and his team to conduct a big systematic literature search for studies evaluating the relationship between testosterone replacement therapy and cardiovascular events among guys. An estimated 13 million men in the USA have problems with low testosterone, which occurs when the body fails to make enough hormones because of a problem with the testicles or pituitary gland. This describes apparent aging, an individual's
sudden weight gain and loss of energy.
And many women have a knee jerk feeling that any hormone treatment can increase their risk of breast cancer. Nevertheless, clinical studies demonstrate that testosterone not only doesn't increase a woman's risk of breast cancer , it may play a key role in warding off the disease. Glaser thinks this will likely remain the status quo for a little while, given the prohibitive cost of running the long-term safety studies needed to gain FDA acceptance that is fuller.